Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

ALXN1830

2 clinical trials

1 indication

Indication
Healthy
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of Subcutaneous ALXN1830 in Healthy Participants
Status: Terminated, Estimated PCD: 2021-01-22
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of Subcutaneous ALXN1830 in Healthy Participants
Status: Terminated, Estimated PCD: 2021-12-14